How has Vertex Pharmaceuticals's defined contribution plan, cost changed year-over-year?

Vertex Pharmaceuticals's defined contribution plan, cost increased by 20.7% year-over-year, from $13.08M to $15.78M.

What is the long-term trend for Vertex Pharmaceuticals's defined contribution plan, cost?

Over 2 years (2023 to 2025), Vertex Pharmaceuticals's defined contribution plan, cost has grown at a 20.3% compound annual growth rate (CAGR), from $43.6M to $63.1M.

Vertex Pharmaceuticals VRTX Defined Contribution Plan, Cost

Defined Contribution Plan, Cost at other companies

Ionis PharmaceuticalsIONS

$2.65M+23.3%

Other financials

Income statement

See full

Revenue$3.0B+7.8%

Gross profit$2.6B+7.8%

Operating income$1.1B+80.6%

Net income$1.0B+59.6%

EPS (diluted)$4.02+61.4%

Balance sheet

See full

Cash & equivalents$5.5B+17.5%

Total debt$2.0B+20.5%

Total equity$19.4B+17.4%

Total assets$26.5B+15.8%

Cash flow

See full

Operating cash flow$1.4B+74.4%

CapEx$133.4M+228%

Free cash flow$1.3B+66.4%

Valuation

See full

Market cap$114.63B-8.9%

Enterprise value$111.11B-9.5%

P/E26.4×—

P/S9.4×-2.0×

Profitability

See full

Gross margin86.2%+0.2pp

Operating margin38.3%—

Net margin35.5%—

FCF margin30.4%+20.2pp

Returns & leverage

See full

Return on equity24.2%—

Debt / equity0.1×0.0×

Current ratio3×+0.4×

Where this comes from

Reported directly by Vertex Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:DefinedContributionPlanCostRecognized.

The official record: Vertex Pharmaceuticals’s 10-K, filed February 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vertex Pharmaceuticals's defined contribution plan, cost.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vertex Pharmaceuticals's defined contribution plan, cost?: Vertex Pharmaceuticals (VRTX) reported defined contribution plan, cost of $15.78M in Q4 2025.
How has Vertex Pharmaceuticals's defined contribution plan, cost changed year-over-year?: Vertex Pharmaceuticals's defined contribution plan, cost increased by 20.7% year-over-year, from $13.08M to $15.78M.
What is the long-term trend for Vertex Pharmaceuticals's defined contribution plan, cost?: Over 2 years (2023 to 2025), Vertex Pharmaceuticals's defined contribution plan, cost has grown at a 20.3% compound annual growth rate (CAGR), from $43.6M to $63.1M.